A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns

ClinicalTrials.gov ID: NCT02148705

Public ClinicalTrials.gov record NCT02148705. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Multinational, Randomized, Controlled, Assessor Blinded Study, Performed in Subjects With Thermal Burns, to Evaluate the Efficacy and Safety of NexoBrid Compared to Gel Vehicle and Compared to Standard of Care

Study identification

NCT ID: NCT02148705
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: MediWound Ltd; Industry
Enrollment: 175 participants

Conditions and interventions

Conditions

Thermal Burns

Interventions

NexoBrid Drug
Standard of Care (SOC) Procedure
Gel Vehicle Drug

Drug · Procedure

Eligibility (public fields only)

Age range: 18 Years to 77 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 26, 2015
Primary completion: Jun 11, 2018
Completion: Aug 19, 2020
Last update posted: Jul 9, 2024

2015 – 2020

United States locations

U.S. sites: 18
U.S. states: 17
U.S. cities: 18

Facility	City	State	ZIP	Site status
University of South Alabama Department of Surgery	Mobile	Alabama	36617	—
Maricopa Medical Center	Phoenix	Arizona	85008	—
University of Colorado at Denver, Teaching	Aurora	Colorado	80045	—
Medstar Washington Hospital Center	Washington D.C.	District of Columbia	20010	—
University of Florida- Dept. of Surgery	Gainesville	Florida	32610	—
Joseph M. Still Research Foundation, Inc.	Augusta	Georgia	30909	—
The University of Iowa Hospitals and Clinics	Iowa City	Iowa	52242	—
Burnett Burn Center at The University of Kansas Hospital	Kansas City	Kansas	66160	—
Johns Hopkins Bayview Medical Center	Baltimore	Maryland	8163	—
The General Hospital Corporation d/b/a Massachusetts General Hospital	Boston	Massachusetts	02114	—
New-York Presbyterian Hospital	New York	New York	10065	—
Emergency Medicine Stony Brook University Hospital	Stony Brook	New York	11794	—
Lehigh Valley Hospital and Health Network	Allentown	Pennsylvania	18103	—
Regional Medical Center ,Regional One Health	Memphis	Tennessee	38103	—
University of Texas Medical Branch	Galveston	Texas	77550	—
University of Utah Hospital	Salt Lake City	Utah	84132	—
HarborView Medical Center	Seattle	Washington	98104	—
Columbia St. Mary's, Inc.	Milwaukee	Wisconsin	53211	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02148705, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 9, 2024 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02148705 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →